|
US20030138438A1
(en)
|
1998-03-18 |
2003-07-24 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20030236209A1
(en)
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
AU2001279581A1
(en)
|
2000-09-06 |
2002-03-22 |
Friederike Muller |
Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter
|
|
US7919467B2
(en)
*
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
EP2113253B1
(en)
|
2008-04-30 |
2010-03-31 |
Immatics Biotechnologies GmbH |
Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
|
|
US20100037514A1
(en)
|
2008-05-13 |
2010-02-18 |
Afton Chemical Corporation |
Fuel additives to maintain optimum injector performance
|
|
ES2532896T5
(es)
*
|
2008-05-14 |
2018-03-20 |
Immatics Biotechnologies Gmbh |
Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan
|
|
RS53782B1
(sr)
|
2008-10-01 |
2015-06-30 |
Immatics Biotechnologies Gmbh |
Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
|
|
US8253536B2
(en)
|
2009-04-22 |
2012-08-28 |
Simon Fraser University |
Security document with electroactive polymer power source and nano-optical display
|
|
TW201124530A
(en)
*
|
2009-12-01 |
2011-07-16 |
Oncotherapy Science Inc |
IMP-3 oligopeptides and vaccines including the same
|
|
US8845620B2
(en)
|
2010-03-16 |
2014-09-30 |
Adapta Medical, Inc. |
Catheter reservoir seals
|
|
GB201004551D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
PL2633020T3
(pl)
|
2010-10-25 |
2019-10-31 |
Stepan Co |
Detergenty do prania na bazie kompozycji pochodzących z metatezy naturalnego oleju
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
ES2617983T3
(es)
|
2011-01-10 |
2017-06-20 |
Ct Atlantic Ltd. |
Terapia de combinación que incluye anticuerpos de unión a antígenos asociados a tumores
|
|
WO2014089124A1
(en)
|
2012-12-03 |
2014-06-12 |
Cenexys, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
WO2014088432A1
(en)
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
CA3051222C
(en)
|
2013-06-10 |
2023-01-24 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for reducing immunosupression by tumor cells
|
|
GB201319446D0
(en)
*
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
ES2738582T3
(es)
|
2014-02-14 |
2020-01-23 |
Immune Design Corp |
Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica
|
|
ES2900262T3
(es)
|
2014-03-17 |
2022-03-16 |
Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch Inst Vertreten Durch Seinen Praeside |
Un medicamento para el uso en un método para inducir o extender una respuesta inmunitaria citotóxica celular
|
|
JP2015227292A
(ja)
|
2014-05-30 |
2015-12-17 |
国立大学法人高知大学 |
膵がん細胞浸潤転移抑制ワクチン
|
|
WO2015187040A1
(en)
|
2014-06-05 |
2015-12-10 |
Regan James Anderson |
Amino sphingoglycolipid analogues
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
LT3388075T
(lt)
*
|
2015-03-27 |
2023-11-10 |
Immatics Biotechnologies Gmbh |
Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš įvairius navikus (seq id 25 - mrax5-003)
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
*
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
*
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
IL308202A
(en)
*
|
2015-05-06 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of oeptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
GB201510771D0
(en)
*
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
TW202231659A
(zh)
*
|
2015-06-19 |
2022-08-16 |
德商英麥提克生物技術股份有限公司 |
用於免疫治療的新穎胜肽及胜肽組合物與產生用於抗胰臟癌及其他癌症的支架的方法
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
MA54884A
(fr)
*
|
2015-07-01 |
2022-01-12 |
Immatics Biotechnologies Gmbh |
Neuartige peptide und kombination aus peptiden zur verwendung in der immuntherapie gegen ovarialkarzinom und andere karzinome
|
|
GB201521746D0
(en)
*
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
|
NZ746387A
(en)
*
|
2016-03-16 |
2022-08-26 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
GB201604490D0
(en)
*
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides combination of peptides for use in immunotherapy against cancers
|
|
WO2017174645A1
(en)
|
2016-04-06 |
2017-10-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
|
|
GB201609193D0
(en)
|
2016-05-25 |
2016-07-06 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
|
|
TWI796299B
(zh)
|
2016-08-26 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
|
SG11201911430PA
(en)
|
2017-07-04 |
2020-01-30 |
Curevac Ag |
Novel nucleic acid molecules
|
|
CN111315769A
(zh)
|
2017-09-06 |
2020-06-19 |
加州理工学院 |
信号传导和抗原呈递双功能受体(sabr)
|
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
JP2022096002A
(ja)
|
2019-04-25 |
2022-06-29 |
三洋化成工業株式会社 |
アルカリ電池用ゲル化剤及びアルカリ電池
|
|
AU2020356334A1
(en)
|
2019-09-24 |
2022-03-31 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|